Loading candles…
Sudeep Pharma Limited, incorporated in 1989 and headquartered in Vadodara, Gujarat, manufactures pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. The company serves the pharmaceutical, food, and nutritional industries by providing mineral-based excipients and specialty ingredients such as calcium-based phosphates and various mineral actives. Sudeep Pharma operates global sales offices in the USA and Europe, distributing its products across more than 50 to over 100 countries worldwide.
This page is a live market overview for SUDEEP PHARMA LIMITED (SUDEEPPHRM) on the NSE. As a listed security, SUDEEP PHARMA LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SUDEEPPHRM before placing trades on tick2trade.
As of the latest feed, SUDEEPPHRM last traded at ₹957.55 on NSE, down ₹16.6 (1.70%) from the previous close of ₹974.15. Today's session range is ₹946.35 – ₹999.95, against a 52-week band of ₹524.05 – ₹999.95. Traded volume today stands at 2.66L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SUDEEPPHRM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SUDEEPPHRM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SUDEEP PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SUDEEPPHRM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SUDEEPPHRM option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 4 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 21 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 6 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 19 Dec 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.